Healthcare CRM Leader Evariant Secures $42.3M Series C Funding and Files for IPO

Latest news reveals that Evariant, a leading CRM provider and healthcare company, announced on December 2, 2015, that it had raised $42.3 million in Series C financing, primarily from Goldman Sachs. Health Enterprise Partners and Lightspeed Venture Partners, which had previously invested in Evariant during its Series A and B rounds, also participated again. Jason Kreuziger, a senior executive at Goldman Sachs, was also appointed to Evariant’s board of directors.



Evariant provides an end-to-end CRM (Customer Relationship Management) platform. “Customer-centricity” is the core philosophy of CRM. CRM represents a convergence of modern information technology and business management principles; leveraging IT as a tool, it creates an automated solution through the strategic integration and design of business processes, aiming to enhance customer loyalty and ultimately improve operational efficiency and drive profit growth. As healthcare reforms deepen, venture capital investment has shifted toward niche sectors, such as Evariant, which offers CRM platform services. The company helps healthcare systems expand their base of patients with medical needs, establish new value-based care delivery models, and thereby strengthen the connection between patients and hospitals. Its seamlessly integrated software platform and analytics solutions have attracted significant attention from healthcare systems, as this innovative platform reduces overall healthcare costs and delivers a better patient experience.

A few years ago, Evariant began challenging the status quo by introducing a bidirectional communication platform specifically designed for patients, healthcare organizations, and other stakeholders. Today, the Evariant platform has not only become an industry-leading provider of truly valuable CRM/PRM systems with synchronized online and offline channels, but it also integrates rich data sources and advanced application features to tackle more complex healthcare challenges. By integrating business data from various healthcare systems, Evariant provides its extensive client base with a powerful, secure, and customizable solution that enhances interaction between patients and healthcare providers, thereby driving further development for marketing, business operations, and physician teams.

Jason Kreuziger, Vice President of Goldman Sachs’ Commercial Investing Division, stated: “Our goal is to invest in companies that are market leaders in their industries and that leverage past experience to propose innovative solutions addressing major healthcare challenges. With more than 600 hospitals and six of the top ten health systems as its clients, Evariant has clearly demonstrated its leadership and innovation capabilities in the healthcare delivery market. As a leading provider of big data services to hospitals, Evariant has transformed many traditional marketing and business development models by launching superior software products and delivering exceptional customer experiences. Complex big data technologies have changed the way healthcare professionals work, enabling the prediction of readmission rates. This allows hospitals to plan and utilize resources more effectively, making healthcare more efficient and personalized.”



In this latest round of financing, Evariant will focus on its engineering, services, and customer success teams, continuously expanding the scope of collaboration with healthcare providers and strengthening communication and connections among all parties. The company recently opened its fourth office in Austin, Texas, serving as its technology hub.

“It is no secret that the healthcare system is facing a variety of exceptionally complex market challenges. Simply aggregating individual solutions for discrete problems does not truly resolve them. However, an integrated platform can scale the healthcare market, analyze current CRM demands within the medical sector, forecast future trends, and maximize user satisfaction,” said William Moschella, CEO of Evariant. “We have pioneered the application of big data and stream analytics, which we believe will soon yield significant market advantages and competitiveness. We are particularly excited about this round of additional investment and will leverage it efficiently to explore core solutions for internet-based healthcare and address how to meet the needs of healthcare systems.”

Data and technology are shaping the leaders of the future healthcare industry. Evariant is committed to providing precise and effective healthcare solutions to medical organizations. By breaking down barriers and obstacles within the healthcare sector and improving methodologies, Evariant is dedicated to an innovative CRM healthcare platform—a system built on a centralized healthcare data center, analytics, and communications—that can identify, execute, and measure all types of engagement initiatives. Many leading healthcare institutions have chosen Evariant’s solutions to optimize their care strategies and related measures, with its global user base exceeding 200,000. Evariant is leveraging big data in healthcare to accelerate growth in business benefits, efficiency, patient care, and other areas.

Compiled by: Chen Kun

Responsible Editor: Zhang Nan